Computed Tomography Arteriograms (CTA) Volume Dose Reduction Study
Status:
Completed
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if the dose of contrast (Omnipaque) administered for
Computed Tomography Arteriograms (CTA) can be reduced without degradation of image quality.
The hypothesis is that there is no difference in image quality using ultra-low dose contrast
in CTA exams compared to routine, standard of care dose exams.